Covid-19 Vaccine Stocks
b'CFRA has a buy rating on the Pfizer (PFE) stock with a $45 price target. They also have a buy rating on Johnson & Johnson (JNJ) with a $177 price target, as well as Novavax (NVAX) with a $200 price target. Sel Hardy examines the outlook for these pharmaceutical stocks.'